Rifampin-resistant Tuberculosis: Clinical Trials

1 trial for Rifampin-resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Rifampin-resistant Tuberculosis: new trials by email Literature Review of Rifampin-resistant Tuberculosis trials Research Report on Rifampin-resistant Tuberculosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
Therapeutic Drug Monitoring for Linezolid - Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis
Not applicableRecruitingAlbert Einstein College of Medicine2802026-04-072026-05-04

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Mycobacterium Infections (1)  ·  Tuberculosis (1)

Interventions

Linezolid (1)

Sponsors

Albert Einstein College of Medicine (1)

Countries

South Africa (1)

Top investigators

Gary Maartens, MBChB (1)  ·  James CM Brust, MD (1)

NIH funding

R01AI184416 (1)